Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
YOU heads into its November earnings with a notable split: short sellers have been trimming positions over the past week, yet the stock has lagged a broadly stronger software peer group, and options traders have rotated into a decisively more bullish posture.
The clearest signal in the data right now is from the options market. Call buying has overtaken puts by a wide margin, with the put/call ratio dropping to 0.44, about one standard deviation below its 20-day average of 0.53. That makes the current reading the most call-heavy it has been in months, the 52-week range runs all the way from zero to 1.28, and the ratio is sitting near the low end. This is not a defensive positioning story. Options traders are leaning into the stock's upside, not hedging against downside.
Short interest tells a more complicated story. Bears are present but retreating at the margin. Short interest runs at 12.5% of the free float, a genuinely elevated level for a mid-cap software name, but the trend over the past week has been lower, down 4.3%. The month-long picture is less clean: shorts have added roughly 6% in aggregate over the past 30 days, meaning the recent pullback follows a larger build. Borrowing costs remain trivially cheap at 0.49%, and borrow availability is extraordinarily loose at nearly 3,000% of current short interest, meaning there is no mechanical friction stopping new shorts from establishing positions if they choose. The ORTEX short score has drifted down to 56.2 from around 58.4 two weeks ago, a modest easing that fits the directional move in SI. Positioning looks occupied but not under pressure.
Analyst sentiment has shifted from cautious optimism to a more mixed picture. DA Davidson, which had been a consistent Buy-rated voice, downgraded YOU to Neutral in May and has since twice trimmed its price target, most recently to $45 in September. JP Morgan initiated with Overweight at $55 in August, putting a more constructive anchor on the Street. Needham remains a bull with a $70 target. Wells Fargo stays at Underweight with a $40 target. The mean target across the group is $59.67, roughly 44% above the current $41.50 print, but that average is heavily influenced by the more optimistic names and partly reflects stale targets from earlier in the year. Bulls point to 31.5% cumulative enrollment growth to 38 million members, a 58% adjusted EBITDA increase, and a $1.05 billion 2026 revenue guide implying 16% growth. Bears focus on five consecutive quarters of declining gross dollar retention, now at 86.4%, and a 2.7% year-on-year drop in annual Clear Plus member usage. Valuation sits at 16.7x trailing earnings and 8.4x EV/EBITDA, with both multiples having compressed modestly over the past month. The EPS surprise factor score at 71 and the 30-day EPS momentum at 70 suggest the earnings track record is better than the retention trend implies.
On ownership, the institutional register is dominated by passive and index capital. BlackRock holds 15.4% of shares and added 787,000 shares in the latest quarter. FMR added over 1.17 million shares, bringing its reported holding to 2.3% from near zero. The Vanguard complex restructured its position, with the parent entity filing a zero-share disclosure in March while Vanguard Portfolio Management filed a fresh 7.3% stake in April. No activist 13D holder is on the register. The insider picture over the past 90 days is one of net selling: insiders disposed of a net $56 million in stock over that period, though the recent open-market transactions have been predominantly under pre-arranged 10b5-1 plans, which reduces their informational weight. The CEO's August transaction was a grant and disposal of 323,904 shares, also plan-driven.
The most interesting alt-data signal is one of absence. Wikipedia traffic on the Clear Secure page is running roughly two standard deviations below its own 90-day average, suggesting that retail attention has fallen away sharply. That is not a revenue or earnings indicator, but it does capture a fading of the name in the retail conversation at a moment when the options market is growing more constructive. None of the alt-data datasets covering YOU has been measured to lead its reported financial figures, so no inference about the November 4 print is warranted. The next report is 28 days away.
Among correlated peers this week, BSY gained 15.6%, ADSK rose 13.8%, and BRZE added 13.8%. YOU's 0.7% weekly gain is modest by comparison, a notable underperformance relative to names with similar correlation profiles. What to watch into November 4 is whether the gross dollar retention metric stabilises after five straight quarters of decline, and whether the gap between bullish options positioning and below-trend retail attention resolves in either direction.
See the live data behind this article on ORTEX.
Open YOU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
